In a predefined subgroup analyzing patients with severe protein C deficiency from the PROWESS-SHOCK, APC treatment did not result in differences in 28-day mortality (28.7% vs 30.8%, n = 673) [36]. This evidence concerns the gene APC and protein c deficiency.